Guiping Yu

445 total citations
24 papers, 318 citations indexed

About

Guiping Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guiping Yu has authored 24 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guiping Yu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Guiping Yu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Guiping Yu collaborates with scholars based in China and United States. Guiping Yu's co-authors include Guoqiang Chen, Bin Huang, Bin Huang, Yong Ji, Song Wu, Song Wu, Lan Wang, Kai Shen, Liqiang Cao and Cheng‐Ying Liu and has published in prestigious journals such as Scientific Reports, RSC Advances and Frontiers in Oncology.

In The Last Decade

Guiping Yu

23 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiping Yu China 12 231 140 41 39 36 24 318
Yunfei Yan China 11 289 1.3× 178 1.3× 39 1.0× 53 1.4× 44 1.2× 27 384
Ruiying Sun China 12 206 0.9× 110 0.8× 33 0.8× 54 1.4× 66 1.8× 28 327
Qunying Wu China 10 243 1.1× 100 0.7× 27 0.7× 58 1.5× 35 1.0× 15 351
Wu-Ping Zheng China 11 225 1.0× 124 0.9× 55 1.3× 49 1.3× 57 1.6× 27 349
Xuyang Hou China 12 304 1.3× 140 1.0× 40 1.0× 69 1.8× 46 1.3× 22 410
Qiangnu Zhang China 12 277 1.2× 217 1.6× 29 0.7× 50 1.3× 65 1.8× 24 372
Xiaohong Du China 12 237 1.0× 166 1.2× 28 0.7× 58 1.5× 49 1.4× 19 374
Federico Lucantoni Spain 10 183 0.8× 84 0.6× 36 0.9× 75 1.9× 28 0.8× 14 333
Yuchen Hou China 12 187 0.8× 102 0.7× 33 0.8× 32 0.8× 71 2.0× 21 311

Countries citing papers authored by Guiping Yu

Since Specialization
Citations

This map shows the geographic impact of Guiping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiping Yu more than expected).

Fields of papers citing papers by Guiping Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiping Yu. The network helps show where Guiping Yu may publish in the future.

Co-authorship network of co-authors of Guiping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Guiping Yu. A scholar is included among the top collaborators of Guiping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiping Yu. Guiping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Guiping, et al.. (2024). ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis. International Immunopharmacology. 144. 113564–113564. 1 indexed citations
2.
Lu, Zhi‐Meng, et al.. (2023). Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma. Frontiers in Cell and Developmental Biology. 11. 1198338–1198338. 2 indexed citations
3.
Yu, Guiping, et al.. (2022). Increased PPARD Expression May Play a Protective Role in Human Lung Adenocarcinoma and Squamous Cell Carcinoma. PPAR Research. 2022. 1–9. 1 indexed citations
4.
Ding, Xiaoling, Xinchen Sun, Lei Wu, et al.. (2022). Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy. Frontiers in Oncology. 11. 786913–786913. 16 indexed citations
5.
Song, Xuming, Te Zhang, Bing Chen, et al.. (2022). Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype. Oncogenesis. 11(1). 61–61. 5 indexed citations
6.
Yu, Guiping, et al.. (2022). Application of three-dimensional reconstruction technology combined with three-dimensional printing in the treatment of pectus excavatum. Annals of Thoracic Medicine. 17(3). 173–179. 2 indexed citations
7.
Yu, Guiping, et al.. (2022). Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1. World Journal of Surgical Oncology. 20(1). 241–241. 43 indexed citations
8.
Yu, Guiping, et al.. (2020). PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma. PPAR Research. 2020. 1–9. 16 indexed citations
9.
Yu, Guiping, et al.. (2020). PEBP4 gene expression in lung squamous cell carcinoma: A meta‑analysis‑based study of the molecular pathways involved. Oncology Letters. 19(4). 2825–2831. 3 indexed citations
11.
Wang, Lan, et al.. (2019). LncRNA LINC00857 regulates lung adenocarcinoma progression, apoptosis and glycolysis by targeting miR-1179/SPAG5 axis. Human Cell. 33(1). 195–204. 46 indexed citations
12.
Huang, Bin, et al.. (2019). Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report. Journal of Cardiothoracic Surgery. 14(1). 161–161. 6 indexed citations
13.
Yu, Guiping, Xia Jiang, Hongbao Cao, & Bin Huang. (2018). Bilateral synchronous multiple lung nodules: Surgical experience from two cases. Saudi Journal of Biological Sciences. 25(5). 971–974. 1 indexed citations
14.
Yu, Guiping, Lishan Tan, Min Li, et al.. (2017). Highly Stabilized Core-Satellite Gold Nanoassemblies in Vivo: DNA-Directed Self-Assembly, PEG Modification and Cell Imaging. Scientific Reports. 7(1). 8553–8553. 14 indexed citations
15.
Yu, Guiping, Ning Zhong, Guoqiang Chen, Bin Huang, & Song Wu. (2014). Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells. Tumor Biology. 35(10). 10341–10349. 30 indexed citations
16.
17.
Wang, Zhong, Guoqiang Chen, Guiping Yu, & Changjian Liu. (2014). Pyrroloquinoline quinone protects mouse brain endothelial cells from high glucose-induced damage in vitro. Acta Pharmacologica Sinica. 35(11). 1402–1410. 18 indexed citations
18.
Yu, Guiping, Bin Huang, Guoqiang Chen, et al.. (2011). PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer. Tumor Biology. 33(1). 223–228. 17 indexed citations
19.
Yu, Guiping, Yong Ji, Guoqiang Chen, et al.. (2011). Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer. Oncology Letters. 3(1). 159–162. 17 indexed citations
20.
Yu, Guiping, Guoqiang Chen, Song Wu, Kai Shen, & Yong Ji. (2011). The expression of PEBP4 protein in lung squamous cell carcinoma. Tumor Biology. 32(6). 1257–1263. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026